Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides
about
Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74Palmitoylation of endothelin receptor A. Differential modulation of signal transduction activity by post-translational modificationMuscarinic acetylcholine receptor subtypes as agonist-dependent oncogenesThe Ca2+-activated polyphosphoinositide phosphodiesterase of human and rabbit neutrophil membranesEvidence that inositol 1-phosphate in brain of lithium-treated rats results mainly from phosphatidylinositol metabolismSignalling through the leukotriene B4 receptor involves both alphai and alpha16, but not alphaq or alpha11 G-protein subunitsBinding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinaseTwo thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutationA molecular mechanism for the effect of lithium on developmentIdentification and characterization of a second melanin-concentrating hormone receptor, MCH-2RArg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorderAn RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transductionExpansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimersSerotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cellsPhosphoinositides: tiny lipids with giant impact on cell regulationInteraction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1Glutamate stimulates inositol phosphate formation in striatal neuronesDemonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptorsMapping of single amino acid residues required for selective activation of Gq/11 by the m3 muscarinic acetylcholine receptorMolecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activityProtein phosphatase-protein kinase interplay modulates alpha 1b-adrenoceptor phosphorylation: effects of okadaic acidAlphaB-crystallin, a low-molecular-weight heat shock protein, acts as a regulator of platelet functionRegulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathwaysConstitutive activation of A(3) adenosine receptors by site-directed mutagenesisInositol lipids, phosphatidate and diacylglycerol share stearoylarachidonoylglycerol as a common backbone in thrombin-stimulated human plateletsAn examination of deoxyadenosine 5'(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptorExpression of a cloned rat histamine H2 receptor mediating inhibition of arachidonate release and activation of cAMP accumulationVisualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type ALuteinizing hormone stimulates the formation of inositol trisphosphate and cyclic AMP in rat granulosa cells. Evidence for phospholipase C generated second messengers in the action of luteinizing hormoneActivation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositidesIntegrins regulate opioid receptor signaling in trigeminal ganglion neuronsMolecular cloning, expression and characterization of cDNA encoding a mouse alpha1a-adrenoceptorPhospholipase C isozymes selectively couple to specific neurotransmitter receptorsSignal transduction by Fc gamma RIII (CD16) is mediated through the gamma chainDifferent single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor familyMolecular basis of V2 vasopressin receptor/Gs coupling selectivityParathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptorThe association of metabotropic glutamate receptor type 5 with the neuronal Ca2+-binding protein 2 modulates receptor function.Ubiquitin is a versatile scaffold protein for the generation of molecules with de novo binding and advantageous drug-like properties
P2860
Q22008605-C51A4903-A641-4105-8CA2-62483AEE4BB2Q24311924-61458EF6-8061-422B-B6FF-3825A62F074CQ24321117-421506A7-81C6-469D-9B5D-671931B2B0EDQ24529158-5512AAE0-8E80-48EB-AB20-136F7A5CDB5DQ24529399-C6D43AD1-3EFF-4623-A6DD-1777A3A63F6CQ24531200-363CD97B-80D2-4779-893E-AEBAFC5580CFQ24562166-D0696E9A-0EF0-43EF-BC09-AAE0B4D54298Q24562692-9AB2A0CB-B0B7-4383-A942-D3D98D92F871Q24629067-4E79AF1A-C5CF-4D64-B1E0-9CFA75E31DF9Q24629423-3A678D7B-2A75-4807-A12B-FF59EF4EC898Q24633040-5AF2F146-EE56-4695-95DE-95A3DD6F9D43Q24681126-EA367846-56AA-4BE2-B18E-F5106FA919D8Q24681398-817204E7-B60E-4A78-B8A2-4040774E1CEAQ24685016-109C737D-91F5-4A61-9E1A-62B240EF4CAEQ27012953-BEE7EE1B-779E-434B-8731-91C2227E7400Q28142235-752DC562-6AB7-498F-8AA5-F6D8518CEEC8Q28143947-1D5B910B-3B08-45B4-8ABC-075BA70D852EQ28282165-22D93E0F-98D2-43F1-8167-F622728E7E5AQ28287661-9344FC79-F0C3-458D-BB77-DD68E4357221Q28294870-075DEC27-0881-407B-9444-0B1ACB5DAED7Q28302291-2BFC9ADE-C287-4B1F-A7CE-D584B70870C5Q28343935-16DFB771-C6B5-4A8F-8580-DF3A9261F3FCQ28346948-8DFAB890-B3BF-4085-AAC4-F97AC54F23FFQ28363743-F5DAD6F2-DA37-4747-B371-B278BE51739BQ28366534-72C428C5-4FCE-487C-B297-713FBE978344Q28366835-D928D3EA-BCAC-4A4C-87CF-7D7CC8513DA6Q28378930-E76A7C95-0404-464C-81A7-AD19516B4472Q28564322-5310E455-7647-4ABE-A948-788C463E604CQ28570961-59C7970B-82D7-41D5-B452-356FFDAD895CQ28577272-84477118-877F-4AED-BAB0-DC431A7BC717Q28581445-8C3F00DB-8C1F-4C93-9457-7F72D6006D3EQ28582209-8A4F7643-7061-450D-B2A1-997CD6AA0C36Q28585213-39EE85E5-9CAB-462D-BA54-A5AC0624309FQ28593039-EFFAF75A-8AC0-452F-82BD-D9F1107DEDAAQ28631978-091D38BB-2AF7-439B-87E6-ACC4CCE226BCQ28640066-6CDC89ED-545A-4301-81E2-0A106399202FQ28640301-FCE66DB0-2D5B-4B85-8FAE-A1944AE1FE42Q28909854-94D3EF79-B520-46AE-89D5-029426096CE7Q29977776-2DA1C721-8B13-4C7B-A18D-A0EB5C5693A5Q30316288-69E8FD65-E284-4354-87B7-F2FFBEFC0C12
P2860
Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides
description
1983 nî lūn-bûn
@nan
1983 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Changes in the levels of inosi ...... of membrane phosphoinositides
@ast
Changes in the levels of inosi ...... of membrane phosphoinositides
@en
Changes in the levels of inosi ...... of membrane phosphoinositides
@en-gb
Changes in the levels of inosi ...... of membrane phosphoinositides
@nl
type
label
Changes in the levels of inosi ...... of membrane phosphoinositides
@ast
Changes in the levels of inosi ...... of membrane phosphoinositides
@en
Changes in the levels of inosi ...... of membrane phosphoinositides
@en-gb
Changes in the levels of inosi ...... of membrane phosphoinositides
@nl
prefLabel
Changes in the levels of inosi ...... of membrane phosphoinositides
@ast
Changes in the levels of inosi ...... of membrane phosphoinositides
@en
Changes in the levels of inosi ...... of membrane phosphoinositides
@en-gb
Changes in the levels of inosi ...... of membrane phosphoinositides
@nl
P2093
P2860
P356
P1433
P1476
Changes in the levels of inosi ...... of membrane phosphoinositides
@en
P2093
C P Downes
J P Heslop
M J Berridge
R F Irvine
R M Dawson
P2860
P304
P356
10.1042/BJ2120473
P407
P577
1983-05-15T00:00:00Z